Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia.
Raktim Kumar Ghosh, Samhati Mondal Ghosh
Index: World J. Urol. 19(5) , 336-43, (2001)
Full Text: HTML
Abstract
Trospium chloride (TCL), a quaternary ammonium derivative of nortropanol, has been evaluated in a number of clinical and pharmacological studies. Selected pharmacological and clinical pharmacokinetic data are discussed as providing a basis for a better interpretation and understanding of the clinical trial results. An overview of the results of 20 clinical trials and post-marketing surveillance studies including more than 10000 patients is presented.
Related Compounds
Related Articles:
New strategies for medical management of overactive bladder in children.
2010-07-01
[Curr. Opin. Urol. 20(4) , 313-7, (2010)]
What is the success of drug treatment in urge urinary incontinence? What should be measured?
2013-03-01
[Arch. Gynecol. Obstet. 287(3) , 511-8, (2013)]
2012-06-19
[Ann. Intern. Med. 156(12) , 861-74, W301-10, (2012)]
2012-10-01
[Biopharm. Drug Dispos. 33(7) , 403-16, (2012)]
2013-09-01
[Eur. J. Pharm. Biopharm. 85(1) , 26-33, (2013)]